Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has provided an update.
Wai Chun Bio-Technology Ltd. has announced its annual general meeting scheduled for March 19, 2025, in Hong Kong. Key agenda items include the re-election of Mr. He Tao as an independent director, the re-appointment of McMillan Woods (Hong Kong) CPA Limited as the company’s auditor, and an ordinary resolution to authorize the company’s directors to issue additional shares or securities. This meeting and the resolutions proposed are significant for the company’s governance and potential expansion efforts, impacting shareholders and the company’s market position.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Ltd. is a company incorporated in the Cayman Islands, primarily focused on biotechnology products and services.
YTD Price Performance: 92.86%
Average Trading Volume: 190,244
Technical Sentiment Consensus Rating: Hold
Current Market Cap: HK$23.15M
For a thorough assessment of 0660 stock, go to TipRanks’ Stock Analysis page.